<?xml version="1.0" encoding="UTF-8"?>
<ref id="B134-pharmaceutics-12-00171">
 <label>134.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Shah</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Agrahari</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Pal</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Mitra</surname>
    <given-names>A.K.</given-names>
   </name>
  </person-group>
  <article-title>Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir</article-title>
  <source>Drug Deliv.</source>
  <year>2015</year>
  <fpage>1</fpage>
  <lpage>11</lpage>
  <pub-id pub-id-type="doi">10.3109/10717544.2014.996833</pub-id>
 </element-citation>
</ref>
